Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial - Tashkin, DP; Roth, MD; Clements, PJ (The Lancet Respiratory Medicine, 2016)